The stock has fallen from a peak back in April.

Vertex Pharmaceuticals has seen its fair value estimate inch up from about $480 to roughly $485 per share as analysts refresh their models around a more constructive long term growth narrative.

Indian Tech Firms Find New Frontier In UAE's Booming Proptech Sector. As India's tech-solution providers push beyond ...

StackSwap represents the next evolution of DeFi on Bitcoin. Built on the Stacks blockchain, it brings decentralized trading, ...

Researchers have discovered that cooling starchy foods—from pizza to rice—creates “resistant starch,” a carb that behaves like fiber and alters your blood sugar response ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

The Indiana Secretary of State’s Office has launched a modernized Notary Education Learning Management System, to improve ...

Only a couple of years since the first sickle cell disease (SCD) gene therapies gained U.S. FDA approval, researchers are working to expand access for younger children, and to improve manufacturing ...

Pickleball courts multiplied, micro-dramas went big, snacking bulked on protein, and diamonds manufactured in labs, India ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, today featured ...

Citi Annual Global Healthcare Conference 2025 December 4, 2025 9:45 AM ESTCompany ParticipantsMichael Cloonan - ...

The new Autumn/Winter 25/26 collection features waterproof, windproof and breathable outerwear – from its fresh Spartan and ...